BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7078779)

  • 1. [Therapeutic use of ornithine-carbamyl-transferase in liver diseases].
    Maccá F; Gatta A; Caregaro L; Lauro S; Milani L; Zuin R; Menozzi L
    Minerva Dietol Gastroenterol; 1982; 28(1):71-8. PubMed ID: 7078779
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent findings in drug treatment of liver disease patients with ornithine-carbamyl-transferase (OCT). Personal experience].
    Alvisi V; Tralli M; Tampieri ML; Lo Ponte A; D'Ambrosi A
    Minerva Dietol Gastroenterol; 1982; 28(4):335-40. PubMed ID: 7167246
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of hepatocellular insufficiency with ornithine carbamyl transferase].
    Heully F; Gaucher P; Jeanpierre R
    Therapeutique; 1972; 48(5):381-4. PubMed ID: 5076530
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of ornithine carbamoyltransferase in the treatment of liver diseases].
    Caruso N; De Jacobis M; Roccato M; Sequino A; Sgoifo B; Tinello M
    Clin Ter; 1984 Jul; 110(1):37-44. PubMed ID: 6237844
    [No Abstract]   [Full Text] [Related]  

  • 5. [Enzymatic therapy in hepatology with ornithine carbamol transferase].
    Monges H; Hancy A; Codinach N
    Mars Med; 1971; 108(12):881-5. PubMed ID: 5145506
    [No Abstract]   [Full Text] [Related]  

  • 6. [A new multienzyme complex. Clinical trial in hepatitis and cirrhosis].
    Ribet A; Vidal JL
    Nouv Presse Med; 1972 Nov; 1(42):2843-4. PubMed ID: 4663747
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinico-biological therapeutic effect of intramuscular ornithine-carbamyl-transferase in chronic active hepatitis].
    Sanchís Closa A; Caballería Rovira E; Arago López JV; Massó Ubeda RM
    Rev Esp Enferm Apar Dig; 1988 Apr; 73(4):351-4. PubMed ID: 3387645
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 9. The activity of serum ornithine-carbamyl transferase in patients with liver cirrhosis.
    Ignatowska-Switalska H; Wasowska-Ciszek T
    Pol Med J; 1969; 8(1):57-61. PubMed ID: 5782170
    [No Abstract]   [Full Text] [Related]  

  • 10. [The treatment of inflammatory liver diseases with 6-mercaptopurine (6-MP)].
    Weinreich J
    Acta Hepatosplenol; 1967; 14(4):189-98. PubMed ID: 5589685
    [No Abstract]   [Full Text] [Related]  

  • 11. [Contribution on the therapy of chronic liver parenchymal damage with 6-mercaptopurine].
    Mott R; Knief J; Faul J
    Med Klin; 1968 Sep; 63(36):1422-8. PubMed ID: 5729432
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of complex therapy on the electrolyte metabolism in patients with chronic hepatitis and liver cirrhosis].
    Rudyk BI
    Vrach Delo; 1973 Sep; 9():89-93. PubMed ID: 4768488
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of urease inhibition in hyperammonemia: clinical and experimental studies with acetohydroxamic acid.
    Summerskill WH; Thorsell F; Feinberg JH; Aldrete JS
    Gastroenterology; 1968 Jan; 54(1):20-6. PubMed ID: 5635434
    [No Abstract]   [Full Text] [Related]  

  • 14. [Activity of guanase and ornithine carbamyl transferase in blood serum of patients with liver disease].
    Boroń P; Kucharski C; Prokopowicz D; Kossakowski R; Neczyperowicz J
    Przegl Lek; 1972; 29(7):675-9. PubMed ID: 5073033
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of liver hydrolysates and corticosteroids in chronic hepatitis and liver cirrhosis].
    Bakulenko EF
    Vrach Delo; 1976 Apr; (4):108-10. PubMed ID: 1007172
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prednisolone therapy of patients with chronic hepatitis and cirrhosis of the liver].
    Vasil'eva LN
    Klin Med (Mosk); 1966 May; 44(5):42-8. PubMed ID: 5990929
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effectiveness of the use of immunosuppressive agents in the treatment of chronic hepatitis and liver cirrhosis].
    Vakulenko EF
    Vrach Delo; 1975 Sep; (9):55-6. PubMed ID: 1210301
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood coagulation activity in patients with chronic hepatitis and cirrhosis of the liver, treated with glucocorticoid hormones].
    Zlatkina AR; Levantovskaia OM; Kravtsova EF
    Ter Arkh; 1972 Apr; 44(4):98-102. PubMed ID: 5051568
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience in the use of the Soviet drug riboxin in therapeutic practice].
    Komarov FI; Ol'binskaia LI; Vartanova OA; Ovchinnikova LV; Pogromov AP
    Sov Med; 1979 Dec; (12):82-3. PubMed ID: 531611
    [No Abstract]   [Full Text] [Related]  

  • 20. [Further clinical experiences with ornithine aspartate in liver diseases].
    Wotzka R; Weber D
    Ther Ggw; 1972 Mar; 111(3):400-12. PubMed ID: 5024593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.